Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma
Status:
Terminated
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
Assessment of safety and tolerability of ADI-PEG 20 in combination with folinic acid
(leucovorin), fluorouracil and oxaliplatin (FOLFOX) in advanced GI malignancies.